Author:
Pruteanu Mihail,Schwarzbach Armin,Berger Markus
Reference9 articles.
1. Bauer Y, Hofmann H, Jahraus O et al (2001) Prominent T cell response to a selectively in vivo expressed Borrelia burgdorferi outer surface protein (pG) in patients with Lyme disease. Eur J Immunol 31(3):767–776. https://doi.org/10.1002/1521-4141(200103)31:3<767::aid-immu767>3.0.co;2-m
2. Rudenko N, Golovchenko M, Grubhoffer L, Oliver JH Jr (2011) Updates on Borrelia burgdorferi sensu lato complex with respect to public health. Ticks Tick Borne Dis 2(3):123–128. https://doi.org/10.1016/j.ttbdis.2011.04.002
3. B. miyamotoi. CDC. Accessed 30 June 2023. https://www.cdc.gov/relapsing-fever/miyamotoi/index.htmL
4. WHO Regional Office for Europe, European Centre for Disease Prevention and Control (2021) Climate-ADAPT. 25 Jun 2021
5. Kugeler KJ, Schwartz AM, Delorey MJ et al (2021) Estimating the frequency of Lyme disease diagnoses, United States, 2010–2018. Emerg Infect Dis 27(2):616–619. https://doi.org/10.3201/eid2702.202731